EGFR and cancer: Of note, IR700DX‐mAb‐based PIT targeting EGFR has been previously demonstrated to be effective in cancers such as breast, lung and bladder by Kobayashi and co‐workers.30, 31, 32, 33, 34 We found that ZEGFR:03115–IR700DX has significant activity in inducing cell death selectively in EGFR+ve GBM cells both in vitro and in vivo.